{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:43:52Z","timestamp":1794469432453,"version":"4.9.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T00:00:00Z","timestamp":1545177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"TESARO, Inc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ygyno.2018.12.009","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T08:48:53Z","timestamp":1547023733000},"page":"560-567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Efficacy and safety of niraparib as maintenance treatment in older patients (\u2265\u202f70\u202fyears) with recurrent ovarian cancer: Results from the ENGOT-OV16\/NOVA trial"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1910-4777","authenticated-orcid":false,"given":"Michel","family":"Fabbro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen N.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"D\u00f8rum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna V.","family":"Tinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Mahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Bover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germana","family":"Tognon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Goffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronnie","family":"Shapira-Frommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Wenham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Hellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Provencher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Harter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel Palacio","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Follana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario J.","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoor R.","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien J.","family":"Hazard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula A.","family":"Matulonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2018.12.009_bb0005","series-title":"Key Statistics for Ovarian Cancer","author":"American Cancer Society","year":"2018"},{"key":"10.1016\/j.ygyno.2018.12.009_bb0010","series-title":"SEER Cancer Statistics Review, 1975-2014, National Cancer Institute","year":"2017"},{"key":"10.1016\/j.ygyno.2018.12.009_bb0015","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/cncr.2820710218","article-title":"Age as a prognostic factor in ovarian carcinoma: the gynecologic oncology group experience","volume":"71","author":"Thigpen","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2018.12.009_bb0020","series-title":"Am. Soc. Clin. Oncol. Educ. Book","first-page":"227","article-title":"Treatment and trials: ovarian cancer in older women","author":"Freyer","year":"2013"},{"key":"10.1016\/j.ygyno.2018.12.009_bb0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2016.03.018","article-title":"Prognostic factors for overall survival in elderly patients with advanced ovarian cancer treated with chemotherapy: results of a pooled analysis of three GINECO phase II trials","volume":"143","author":"Tinquaut","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.12.009_bb0030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ygyno.2005.04.037","article-title":"Treatment patterns by decade of life in elderly women (\u226570\u202fyears of age) with ovarian cancer","volume":"98","author":"Uyar","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.12.009_bb0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fonc.2016.00063","article-title":"The application and outcome of standard of care treatment in elderly women with ovarian cancer: a literature review over the last 10\u202fyears","volume":"6","author":"Gibson","year":"2016","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ygyno.2018.12.009_bb0040","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/annonc\/mdl401","article-title":"Feasibility, toxicity and quality of life of first-line chemotherapy with platinum\/paclitaxel in elderly patients aged \u226570\u202fyears with advanced ovarian cancer\u2013a study by the AGO OVAR Germany","volume":"18","author":"Hilpert","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2018.12.009_bb0045","series-title":"NRG Oncology\/Gynecologic Oncology Group study","first-page":"459","article-title":"Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer\u2013an","volume":"144","author":"von Gruenigen","year":"2017"},{"key":"10.1016\/j.ygyno.2018.12.009_bb0050","unstructured":"National Comprehensive Cancer Network (NCCN), NCCN Clinical Practice Guidelines in Oncology: Senior Adult Oncology. V2.2017 ed2017."},{"key":"10.1016\/j.ygyno.2018.12.009_bb0055","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1056\/NEJMoa1611310","article-title":"Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer","volume":"375","author":"Mirza","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2018.12.009_bb0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ctrv.2016.08.007","article-title":"Improving outcomes for older women with gynaecological malignancies","volume":"50","author":"Dumas","year":"2016","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ygyno.2018.12.009_bb0065","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1634\/theoncologist.5-3-224","article-title":"Management of cancer in the older person: a practical approach","volume":"5","author":"Balducci","year":"2000","journal-title":"Oncologist"},{"key":"10.1016\/j.ygyno.2018.12.009_bb0070","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ygyno.2017.10.007","article-title":"Tolerance and toxicity of the PARP inhibitor olaparib in older women with epithelial ovarian cancer","volume":"147","author":"Dockery","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.12.009_bb0075","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJMc1616633","article-title":"Niraparib in recurrent ovarian cancer","volume":"376","author":"Schram","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2018.12.009_bb0080","doi-asserted-by":"crossref","first-page":"16633","DOI":"10.1073\/pnas.0708043104","article-title":"Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations","volume":"104","author":"Feng","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818314732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818314732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:41:27Z","timestamp":1758771687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825818314732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0090825818314732"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.12.009","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of niraparib as maintenance treatment in older patients (\u2265\u202f70\u202fyears) with recurrent ovarian cancer: Results from the ENGOT-OV16\/NOVA trial","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}